NYSE:SCM - Stellus Capital Investment Stock Price, Forecast & News

Stellus Capital Investment trades on the New York Stock Exchange (NYSE) under the ticker symbol "SCM."

Stellus Capital Investment declared a monthly dividend on Wednesday, January 15th. Shareholders of record on Tuesday, March 31st will be paid a dividend of $0.1133 per share on Wednesday, April 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 10.85%. The ex-dividend date of this dividend is Monday, March 30th. View Stellus Capital Investment's Dividend History.

Stellus Capital Investment Corp (NYSE:SCM) released its earnings results on Thursday, November, 7th. The investment management company reported $0.31 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.31. The investment management company earned $15.52 million during the quarter, compared to analysts' expectations of $14.61 million. Stellus Capital Investment had a net margin of 45.89% and a return on equity of 9.44%. View Stellus Capital Investment's Earnings History.

Stellus Capital Investment is scheduled to release their next quarterly earnings announcement on Tuesday, March 3rd 2020. View Earnings Estimates for Stellus Capital Investment.

Stellus Capital Investment will be holding an earnings conference call on Tuesday, March 3rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stellus Capital Investment in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Stellus Capital Investment.

News coverage about SCM stock has trended very negative this week, according to InfoTrie. The research firm ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Stellus Capital Investment earned a daily sentiment score of -3.2 on InfoTrie's scale. They also gave headlines about the investment management company a news buzz of 4.0 out of 10, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next few days. View News Stories for Stellus Capital Investment.

Stellus Capital Investment saw a drop in short interest during the month of January. As of January 31st, there was short interest totalling 264,300 shares, a drop of 10.6% from the January 15th total of 295,700 shares. Based on an average daily trading volume, of 99,100 shares, the days-to-cover ratio is presently 2.7 days. Approximately 1.5% of the company's stock are short sold. View Stellus Capital Investment's Current Options Chain.

Some companies that are related to Stellus Capital Investment include BlackRock (BLK), Bank of New York Mellon (BK), T. Rowe Price Group (TROW), State Street (STT), Ameriprise Financial (AMP), Northern Trust (NTRS), Franklin Resources (BEN), SEI Investments (SEIC), Ares Capital (ARCC), Invesco (IVZ), Eaton Vance (EV), Legg Mason (LM), Affiliated Managers Group (AMG), Cohen & Steers (CNS) and Federated Investors (FII).

Based on aggregate information from My MarketBeat watchlists, some companies that other Stellus Capital Investment investors own include Energy Transfer LP Unit (ET), New Residential Investment (NRZ), Ares Capital (ARCC), Prospect Capital (PSEC), Oxford Lane Capital (OXLC), Hercules Capital (HTGC), AT&T (T), AGNC Investment (AGNC), Capitala Finance (CPTA) and Gladstone Investment (GAIN).

Stellus Capital Investment's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Confluence Investment Management LLC (2.38%), UBS Group AG (1.63%), Virtus ETF Advisers LLC (1.58%), Advisors Asset Management Inc. (1.52%), Muzinich & Co. Inc. (0.89%) and Raymond James & Associates (0.53%). Company insiders that own Stellus Capital Investment stock include Bruce R Bilger, Dean D'angelo, Joshua T Davis, Robert T Ladd and W Todd Huskinson. View Institutional Ownership Trends for Stellus Capital Investment.

SCM stock was sold by a variety of institutional investors in the last quarter, including Confluence Investment Management LLC, Muzinich & Co. Inc., UBS Group AG, Virtus ETF Advisers LLC, Acadian Asset Management LLC, Advisory Research Inc., Raymond James & Associates and LSV Asset Management. View Insider Buying and Selling for Stellus Capital Investment.

SCM stock was purchased by a variety of institutional investors in the last quarter, including Marshall Wace LLP, Chapwood Capital Investment Management LLC, Guild Investment Management Inc., Raymond James Trust N.A., California Public Employees Retirement System, Great West Life Assurance Co. Can, Stifel Financial Corp and Ladenburg Thalmann Financial Services Inc.. Company insiders that have bought Stellus Capital Investment stock in the last two years include Bruce R Bilger, Dean D'angelo, Joshua T Davis, Robert T Ladd and W Todd Huskinson. View Insider Buying and Selling for Stellus Capital Investment.

Shares of SCM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of SCM stock can currently be purchased for approximately $12.53.

Stellus Capital Investment has a market capitalization of $236.89 million and generates $53.27 million in revenue each year. The investment management company earns $26.19 million in net income (profit) each year or $1.42 on an earnings per share basis. View Additional Information About Stellus Capital Investment.

The official website for Stellus Capital Investment is http://www.stelluscapital.com/.

Stellus Capital Investment's mailing address is 4400 POST OAK PARKWAY SUITE 2200, HOUSTON TX, 77027. The investment management company can be reached via phone at 713-292-5400.